- cafead   Jun 27, 2018 at 09:52: AM
via AstraZeneca's oncology business received a boost on Wednesday as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live longer without their disease worsening when given as a first-line treatment.
article source
article source